November 9, 2026
SOHO Insider Hem/Onc Library Meetings / Conferences SOHO 2025 Leukemia News Drs. Kantarjian and Short detail ALL treatment shift at SOHO 2025
Short & Kantarjian
Meetings / Conferences SOHO 2025 Leukemia News News Video Interviews

Drs. Kantarjian and Short detail ALL treatment shift at SOHO 2025

  • by
  • October 13, 2025
  • 0 Comments
  • Less than a minute
  • 1431 Views
  • 1 year ago

In this interview from the Thirteenth annual meeting of the Society of Hematologic Oncology (SOHO 2025), Hagop Kantarjian, MD, hosts Nicholas Short, MD, both from the University of Texas MD Anderson Cancer Center, to discuss progress in acute lymphoblastic leukemia (ALL) treatment.

Watch more discussions from SOHO 2025.

Share This Post:

Leave feedback about this

  • Quality
  • Price
  • Service

PROS

+
Add Field

CONS

+
Add Field

Related Post

Lymphoma, Aggressive B-Cell Lymphomas, News

Pathways & Perspectives with Ann LaCasce, MD, MMSc

November 9, 2026
Lymphoma, Mantle Cell Lymphoma, Video Interviews

Elise Chong, MD, discusses real-world CIBMTR analysis of liso-cel in R/R MCL

November 6, 2026
Leukemia, Acute Lymphoblastic Leukemia, Video Interviews

Blood Cancer United president reflects on 75 years of progress in blood cancer treatment

November 4, 2026
Insider_Podcast_Patel_Xavier_400x400
Trending now, News, SOHO Insider Podcast

Dr. Krish Patel on frontline and relapsed management strategies in mantle cell lymphoma

November 3, 2026
Trending now, Meetings / Conferences, SOHO France, Young Investigator Program

Meet SOHO France Young Investigator Syrine Bel Haj Yahia

October 31, 2026
FDA
Trending now, Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, News

FDA grants Breakthrough Designation to enzomenib for relapsed or refactory acute leukemia

October 30, 2026